Tissue Engineering and Cell Transplantation: U.S. Markets for Organ Regeneration Products

In the United States (U.S.), tissue engineering technologies for organ regeneration are being developed for a variety of clinical applications including bone marrow disease, cardiovascular disease, diabetes, end-stage renal disease, intestinal disorders, liver disease, and urologic disorders.

Cardiovascular applications for organ regeneration are reviewed in depth in Medtech Insight’s report #A421, “U.S. Markets for Cardiac and Vascular Tissue Engineering Products.” Urogenital applications for organ regeneration are discussed in Medtech Insight’s report #A424, “U.S. Markets for Urogenital Tissue Engineering and Cell Transplantation Products.”